Work

Leveraging Biopharmaceutics Bridging Risk Assessment and In Vivo Predictive Tools to Accelerate Immediate Release Drug Product Development by Minimized Need for Clinical Bridging Studies

Year: 2025

Type: article

Source: Molecular Pharmaceutics

DOI: 10.1021/acs.molpharmaceut.5c00910

Authors: Helena Engman, Sara Carlert, Maria Hammarberg, Richard Barker, James Mann, Anders Borde, Eva Karlsson, Johan Palm, Bertil Abrahamsson, Christer Tannergren

Institutions: AstraZeneca (United Kingdom), AstraZeneca (Sweden)

Language: English

Topic: Drug Solubulity and Delivery Systems

Subfield: Pharmaceutical Science

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414416578

FWCI: 1.685

Cites: 57

Cited by: 5

Related to: